Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome
Julien Zuber(Délégation Paris 5), Megan Sykes(Columbia University Irving Medical Center), Mercedes Martínez(Columbia University), Shana M. Coley(Arkana Laboratories), Susan DeWolf(Memorial Sloan Kettering Cancer Center), Aleksandar Obradović(Columbia University), Sai Ping Lau(Erasmus MC), Tomoaki Kato(Columbia University Irving Medical Center), Yufeng Shen(Columbia University Irving Medical Center), Adam Griesemer(Harvard University), Jianing Fu(Columbia University Irving Medical Center), Donna L. Färber(Columbia University Irving Medical Center), Brittany Shonts(Columbia University), Joseph Thome(Columbia University Irving Medical Center), Joshua Weiner(Columbia University Irving Medical Center), Suxiao Yang(Columbia University Irving Medical Center), Sophie Caillat‐Zucman(Université Paris Cité), Marion Lambert(Inserm), Govind Bhagat(Columbia University Irving Medical Center)
Cited by 135
Related Papers
The support of human genetic evidence for approved drug indications
|Nature Genetics|2015|1.8k
The Genome of the Sea Urchin <i>Strongylocentrotus purpuratus</i>
|Science|2006|1.2k
Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites
|Cell Reports|2017|1.1k
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
|Nature Genetics|2009|1.1k